{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T13:02:17Z","timestamp":1785157337817,"version":"3.55.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Swiss Government Excellence Scholarships (ESKAS) Programme","award":["No Grant ID"],"award-info":[{"award-number":["No Grant ID"]}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PR00P3_179753 \/ 1"],"award-info":[{"award-number":["PR00P3_179753 \/ 1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PR00P3_179753 \/ 1"],"award-info":[{"award-number":["PR00P3_179753 \/ 1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008375","name":"University of Basel","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Schistosomiasis is a debilitating neglected tropical disease endemic in sub-Saharan Africa. The role of health facilities in the prevention, diagnosis, control, and elimination of schistosomiasis is poorly documented. In a setting targeted for schistosomiasis elimination in Zanzibar, we assessed the prevalence of <jats:italic>Schistosoma haematobium<\/jats:italic> among patients seeking care in a health facility and investigated schistosomiasis-related knowledge of staff, and health facilities\u2019 capacities and needs for schistosomiasis diagnosis and management.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a health facility-based mixed-method study on Pemba Island from June to August 2023. Patients aged\u2009\u2265\u20094\u00a0years seeking care in four health facilities were screened for <jats:italic>S.\u00a0haematobium<\/jats:italic> infection using urine filtration and reagent strips. Those patients aged\u2009\u2265\u200910\u00a0years were additionally interviewed about signs and symptoms. Staff from 23 health facilities responded to a questionnaire assessing knowledge and practices. Ten staff participated in a focus group discussion (FGD) about capacities and needs for schistosomiasis diagnosis and management.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The prevalence of <jats:italic>S.\u00a0haematobium<\/jats:italic> infection in patients attending the health facilities, as determined by the presence of eggs in urine, was 1.1% (8\/712). Microhaematuria was detected in 13.3% (95\/712) of the patients using reagent strips. Among patients responding to the questionnaire, pelvic pain, pain during sex, and painful urination were reported by 38.0% (237\/623), 6.3% (39\/623), and 3.2% (20\/623), respectively. Among the health facility staff, 90.0% (44\/49) and 87.8% (43\/49) identified blood in urine and pelvic pain, respectively, as symptoms of urogenital schistosomiasis, 81.6% (40\/49) and 93.9% (46\/49) reported collecting a urine sample and pursuing a reagent strip test, respectively, for diagnosis, and 87.8% (43\/49) administered praziquantel for treatment. The most reoccurring themes in the FGD were the need for more staff training about schistosomiasis, requests for diagnostic equipment, and the need to improve community response to schistosomiasis services in health facilities.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The prevalence of <jats:italic>S.\u00a0haematobium<\/jats:italic> infection in patients seeking care in health facilities in Pemba is very low and similar to what has been reported from recent community-based cross-sectional surveys. The health facility staff had good schistosomiasis-related knowledge and practices. However, to integrate schistosomiasis patient management more durably into routine health facility activities, scalable screening pathways need to be identified and capacities need to be improved by regular staff training, and an unbroken supply of accurate point-of-care diagnostics and praziquantel for the treatment of cases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13071-024-06311-8","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T12:02:24Z","timestamp":1718625744000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Capacities and needs of health care facilities for schistosomiasis diagnosis and management in elimination settings"],"prefix":"10.1186","volume":"17","author":[{"given":"Naomi C.","family":"Ndum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Trippler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulfat A.","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisa S.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Hattendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrg","family":"Utzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said M.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Knopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,17]]},"reference":[{"key":"6311_CR1","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","volume":"383","author":"DG Colley","year":"2014","unstructured":"Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet. 2014;383:2253\u201364.","journal-title":"Lancet"},{"key":"6311_CR2","volume-title":"Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021\u20132030","author":"WHO","year":"2020","unstructured":"WHO. Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021\u20132030. Geneva: World Health Organization; 2020."},{"key":"6311_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-018-0013-8","volume":"4","author":"DP McManus","year":"2018","unstructured":"McManus DP, Dunne DW, Sacko M, Utzinger J, Vennervald BJ, Zhou X-N. Schistosomiasis. Nat Rev Dis Primers. 2018;4:13.","journal-title":"Nat Rev Dis Primers"},{"key":"6311_CR4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.idc.2012.03.004","volume":"26","author":"B Gryseels","year":"2012","unstructured":"Gryseels B. Schistosomiasis. Infect Dis Clin North Am. 2012;26:383\u201397.","journal-title":"Infect Dis Clin North Am"},{"key":"6311_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.apar.2021.12.003","volume":"115","author":"AL Bustinduy","year":"2022","unstructured":"Bustinduy AL, Randriansolo B, Sturt AS, Kayuni SA, Leutscher PD, Webster BL, et al. An update on female and male genital schistosomiasis and a call to integrate efforts to escalate diagnosis, treatment and awareness in endemic and non-endemic settings: the time is now. Adv Parasitol. 2022;115:1\u201344.","journal-title":"Adv Parasitol"},{"key":"6311_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S1473-3099(21)00090-6","volume":"22","author":"C Kokaliaris","year":"2022","unstructured":"Kokaliaris C, Garba A, Matuska M, Bronzan RN, Colley DG, Dorkenoo AM, et al. Effect of preventive chemotherapy with praziquantel on schistosomiasis among school-aged children in sub-Saharan Africa: a spatiotemporal modelling study. Lancet Infect Dis. 2022;22:136\u201349.","journal-title":"Lancet Infect Dis"},{"key":"6311_CR7","volume-title":"Global report on neglected tropical diseases","author":"WHO","year":"2023","unstructured":"WHO. Global report on neglected tropical diseases. Geneva: World Health Organization; 2023."},{"key":"6311_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007268","volume":"13","author":"S Knopp","year":"2019","unstructured":"Knopp S, Ame SM, Person B, Hattendorf J, Rabone M, Juma S, et al. A 5-year intervention study on elimination of urogenital schistosomiasis in Zanzibar: parasitological results of annual cross-sectional surveys. PLoS Negl Trop Dis. 2019;13:e0007268.","journal-title":"PLoS Negl Trop Dis"},{"key":"6311_CR9","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMoa1812165","volume":"381","author":"AK Deol","year":"2019","unstructured":"Deol AK, Fleming FM, Calvo-Urbano B, Walker M, Bucumi V, Gnandou I, et al. Schistosomiasis\u2014assessing progress toward the 2020 and 2025 global goals. N Engl J Med. 2019;381:2519\u201328.","journal-title":"N Engl J Med"},{"key":"6311_CR10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S1473-3099(22)00221-3","volume":"22","author":"NC Lo","year":"2022","unstructured":"Lo NC, Bezerra FSM, Colley DG, Fleming FM, Homeida M, Kabatereine N, et al. Review of 2022 WHO guidelines on the control and elimination of schistosomiasis. Lancet Infect Dis. 2022;22:327\u201335.","journal-title":"Lancet Infect Dis"},{"key":"6311_CR11","volume-title":"Preventive chemotherapy in human helminthiasis. Coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers","author":"WHO","year":"2006","unstructured":"WHO. Preventive chemotherapy in human helminthiasis. Coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. Geneva: World Health Organization; 2006."},{"key":"6311_CR12","volume-title":"WHO guideline on control and elimination of human schistosomiasis","author":"WHO","year":"2022","unstructured":"WHO. WHO guideline on control and elimination of human schistosomiasis. Geneva: World Health Organization; 2022."},{"key":"6311_CR13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.actatropica.2012.04.013","volume":"128","author":"D Rollinson","year":"2013","unstructured":"Rollinson D, Knopp S, Levitz S, Stothard JR, Tchuem Tchuent\u00e9 LA, Garba A, et al. Time to set the agenda for schistosomiasis elimination. Acta Trop. 2013;128:423\u201340.","journal-title":"Acta Trop"},{"key":"6311_CR14","doi-asserted-by":"publisher","first-page":"e1118","DOI":"10.1016\/S2214-109X(19)30189-5","volume":"7","author":"S Knopp","year":"2019","unstructured":"Knopp S, Person B, Ame SM, Ali SM, Hattendorf J, Juma S, et al. Evaluation of integrated interventions layered on mass drug administration for urogenital schistosomiasis elimination: a cluster-randomised trial. Lancet Glob Health. 2019;7:e1118\u201329.","journal-title":"Lancet Glob Health"},{"key":"6311_CR15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s13071-015-0766-9","volume":"8","author":"JET Grimes","year":"2015","unstructured":"Grimes JET, Croll D, Harrison WE, Utzinger J, Freeman MC, Templeton MR. The roles of water, sanitation and hygiene in reducing schistosomiasis: a review. Parasit Vectors. 2015;8:156.","journal-title":"Parasit Vectors"},{"key":"6311_CR16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s13071-019-3757-4","volume":"12","author":"K Mekete","year":"2019","unstructured":"Mekete K, Ower A, Dunn J, Sime H, Tadesse G, Abate E, et al. The Geshiyaro project: a study protocol for developing a scalable model of interventions for moving towards the interruption of the transmission of soil-transmitted helminths and schistosome infections in the Wolaita zone of Ethiopia. Parasit Vectors. 2019;12:503.","journal-title":"Parasit Vectors"},{"key":"6311_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000867","volume":"4","author":"A Danso-Appiah","year":"2010","unstructured":"Danso-Appiah A, Stolk WA, Bosompem KM, Otchere J, Looman CW, Habbema JDF, et al. Health seeking behaviour and utilization of health facilities for schistosomiasis-related symptoms in Ghana. PLoS Negl Trop Dis. 2010;4:e867.","journal-title":"PLoS Negl Trop Dis"},{"key":"6311_CR18","doi-asserted-by":"publisher","first-page":"i43","DOI":"10.1093\/inthealth\/ihad006","volume":"15","author":"M Nganda","year":"2023","unstructured":"Nganda M, Bettee AK, Kollie K, Nallo GE, Juabeh M, Wright A, et al. Incorporating the diagnosis and management of female genital schistosomiasis in primary healthcare in Liberia: a mixed methods pilot study. Int Health. 2023;15:i43\u201351.","journal-title":"Int Health"},{"key":"6311_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009669","volume":"15","author":"L De Boni","year":"2021","unstructured":"De Boni L, Msimang V, De Voux A, Frean J. Trends in the prevalence of microscopically-confirmed schistosomiasis in the South African public health sector, 2011\u20132018. PLoS Negl Trop Dis. 2021;15:e0009669.","journal-title":"PLoS Negl Trop Dis"},{"key":"6311_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s40249-018-0447-y","volume":"7","author":"P Bizimana","year":"2018","unstructured":"Bizimana P, Polman K, Van Geertruyden J-P, Nsabiyumva F, Ngenzebuhoro C, Muhimpundu E, et al. Capacity gaps in health facilities for case management of intestinal schistosomiasis and soil-transmitted helminthiasis in Burundi. Infect Dis Poverty. 2018;7:66.","journal-title":"Infect Dis Poverty"},{"key":"6311_CR21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s13071-019-3652-z","volume":"12","author":"P Bizimana","year":"2019","unstructured":"Bizimana P, Ortu G, Van Geertruyden J-P, Nsabiyumva F, Nkeshimana A, Muhimpundu E, et al. Integration of schistosomiasis control activities within the primary health care system: a critical review. Parasit Vectors. 2019;12:393.","journal-title":"Parasit Vectors"},{"key":"6311_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009127","volume":"15","author":"L Trippler","year":"2021","unstructured":"Trippler L, Ame SM, Hattendorf J, Juma S, Abubakar S, Ali SM, et al. Impact of seven years of mass drug administration and recrudescence of Schistosoma haematobium infections after one year of treatment gap in Zanzibar: repeated cross-sectional studies. PLoS Negl Trop Dis. 2021;15:e0009127.","journal-title":"PLoS Negl Trop Dis"},{"key":"6311_CR23","doi-asserted-by":"publisher","first-page":"e1355","DOI":"10.1016\/S2214-109X(22)00287-X","volume":"10","author":"RE Wiegand","year":"2022","unstructured":"Wiegand RE, Fleming FM, de Vlas SJ, Odiere MR, Kinung\u2019hi S, King CH, et al. Defining elimination as a public health problem for schistosomiasis control programmes: beyond prevalence of heavy-intensity infections. Lancet Glob Health. 2022;10:e1355\u20139.","journal-title":"Lancet Glob Health"},{"key":"6311_CR24","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3390\/tropicalmed7110382","volume":"7","author":"TG Nemungadi","year":"2022","unstructured":"Nemungadi TG, Furumele TE, Gugerty MK, Djirmay AG, Naidoo S, Kjetland EF. Establishing and integrating a female genital schistosomiasis control programme into the existing health care system. Trop Med Infect Dis. 2022;7:382.","journal-title":"Trop Med Infect Dis."},{"key":"6311_CR25","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/bs.apar.2023.06.001","volume":"122","author":"L Trippler","year":"2023","unstructured":"Trippler L, Knopp S, Welsche S, Webster BL, Stothard JR, Blair L, et al. The long road to schistosomiasis elimination in Zanzibar: a systematic review covering 100 years of research, interventions and control milestones. Adv Parasitol. 2023;122:71\u2013191.","journal-title":"Adv Parasitol"},{"key":"6311_CR26","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1186\/s12879-021-06620-8","volume":"21","author":"L Trippler","year":"2021","unstructured":"Trippler L, Hattendorf J, Ali SM, Ame SM, Juma S, Kabole F, et al. Novel tools and strategies for breaking schistosomiasis transmission: study protocol for an intervention study. BMC Infect Dis. 2021;21:1024.","journal-title":"BMC Infect Dis"},{"key":"6311_CR27","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13071-022-05404-6","volume":"15","author":"L Trippler","year":"2022","unstructured":"Trippler L, Ali SM, Ame SM, Hattendorf J, Suleiman KR, Ali MN, et al. Fine-scale-mapping of Schistosoma haematobium infections at the school and community levels and intermediate host snail abundance in the north of Pemba Island: baseline cross-sectional survey findings before the onset of a 3-year intervention study. Parasit Vectors. 2022;15:292.","journal-title":"Parasit Vectors"},{"key":"6311_CR28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ocecoaman.2017.10.003","volume":"149","author":"ZA Khamis","year":"2017","unstructured":"Khamis ZA, Kalliola R, K\u00e4yhk\u00f6 N. Geographical characterization of the Zanzibar coastal zone and its management perspectives. Ocean Coast Manage. 2017;149:116\u201334.","journal-title":"Ocean Coast Manage"},{"key":"6311_CR29","unstructured":"Office of the Chief Government Statistician Zanzibar. The United Republic of Tanzania (URT), Ministry of Finance and Planning, Tanzania National Bureau of Statistics and President\u2019s Office - Finance and Planning, Office of the Chief Government Statistician, Zanzibar. The 2022 population and housing census: administrative units population distribution report; Tanzania, Zanzibar, December 2022."},{"key":"6311_CR30","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4269\/ajtmh.2012.12-0288","volume":"88","author":"LM Kaljee","year":"2013","unstructured":"Kaljee LM, Pach A, Thriemer K, Ley B, Ali SM, Jiddawi M, et al. Utilization and accessibility of healthcare on Pemba Island, Tanzania: implications for health outcomes and disease surveillance for typhoid fever. Am J Trop Med Hyg. 2013;88:144\u201352.","journal-title":"Am J Trop Med Hyg"},{"key":"6311_CR31","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1186\/s12913-021-06867-6","volume":"21","author":"F Saleh","year":"2021","unstructured":"Saleh F, Kitau J, Konradsen F, Mboera LE, Schi\u00f8ler KL. Emerging epidemics: is the Zanzibar healthcare system ready to detect and respond to mosquito-borne viral diseases? BMC Health Serv Res. 2021;21:866.","journal-title":"BMC Health Serv Res"},{"key":"6311_CR32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40985-019-0114-2","volume":"40","author":"H Nkata","year":"2019","unstructured":"Nkata H, Teixeira R, Barros H. A scoping review on sexual and reproductive health behaviors among Tanzanian adolescents. Public Health Rev. 2019;40:4.","journal-title":"Public Health Rev"},{"key":"6311_CR33","doi-asserted-by":"crossref","unstructured":"Eustace RW, Nyamhanga TM, Ghuhiya AI, Mushy SE. Family life education development, implementation, and evaluation in Tanzania. In: Robila M &\u00b7Taylor AC (eds) Global Perspectives on Family Life Education. 2018. p. 135\u201351.","DOI":"10.1007\/978-3-319-77589-0_9"},{"key":"6311_CR34","volume-title":"Guidelines for the evaluation of soil-transmitted helminthiasis and schistosomiasis at community level: a guide for managers of control programmes","author":"A Montresor","year":"1998","unstructured":"Montresor A, Crompton DWT, Hall A, Bundy DAP, Savioli L. Guidelines for the evaluation of soil-transmitted helminthiasis and schistosomiasis at community level: a guide for managers of control programmes. Geneva: World Health Organization; 1998."},{"key":"6311_CR35","first-page":"2011","volume":"26","author":"KA Campbell","year":"2021","unstructured":"Campbell KA, Orr E, Durepos P, Nguyen L, Li L, Whitmore C, et al. Reflexive thematic analysis for applied qualitative health research. Qual Rep. 2021;26:2011\u201328.","journal-title":"Qual Rep"},{"key":"6311_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011465","volume":"17","author":"T Ursini","year":"2023","unstructured":"Ursini T, Scarso S, Mugassa S, Othman JB, Yussuph AJ, Ndaboine E, et al. Assessing the prevalence of female genital schistosomiasis and comparing the acceptability and performance of health worker-collected and self-collected cervical-vaginal swabs using PCR testing among women in north-western Tanzania: The ShWAB study. PLoS Negl Trop Dis. 2023;17:e0011465.","journal-title":"PLoS Negl Trop Dis"},{"key":"6311_CR37","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s12913-021-06531-z","volume":"21","author":"HD Mazigo","year":"2021","unstructured":"Mazigo HD, Uisso C, Kazyoba P, Mwingira UJ. Primary health care facilities capacity gaps regarding diagnosis, treatment and knowledge of schistosomiasis among healthcare workers in north-western Tanzania: a call to strengthen the horizontal system. BMC Health Serv Res. 2021;21:529.","journal-title":"BMC Health Serv Res"},{"key":"6311_CR38","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1179\/000349803225001544","volume":"97","author":"A Landoure","year":"2003","unstructured":"Landoure A, Van der Werf M, Traor\u00e9 M, de Vlas S. Evaluation of case management in the integrated schistosomiasis-control programme in Mali. Ann Trop Med Parasitol. 2003;97:723\u201336.","journal-title":"Ann Trop Med Parasitol"},{"key":"6311_CR39","unstructured":"Minist\u00e8re de la Sant\u00e9 Publique et de la Lutte contre le Sida. Burundi liste des medicaments essentielles Burundi, Bujumbura. 2012."},{"key":"6311_CR40","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1186\/s13071-018-3136-6","volume":"11","author":"S Knopp","year":"2018","unstructured":"Knopp S, Ame SM, Hattendorf J, Ali SM, Khamis IS, Bakar F, et al. Urogenital Schistosoma haematobium in Zanzibar: accuracy of urine filtration and haematuria reagent strips for diagnosing light intensity Schistosoma haematobium infections. Parasit Vectors. 2018;11:552.","journal-title":"Parasit Vectors"},{"key":"6311_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003752","volume":"9","author":"S Knopp","year":"2015","unstructured":"Knopp S, Corstjens PL, Koukounari A, Cercamondi CI, Ame SM, Ali SM, et al. Sensitivity and specificity of a urine circulating anodic antigen test for the diagnosis of Schistosoma haematobium in low endemic settings. PLoS Negl Trop Dis. 2015;9:e0003752.","journal-title":"PLoS Negl Trop Dis"},{"key":"6311_CR42","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13071-015-0857-7","volume":"8","author":"PL Corstjens","year":"2015","unstructured":"Corstjens PL, Nyakundi RK, de Dood CJ, Kariuki TM, Ochola EA, Karanja DM, et al. Improved sensitivity of the urine CAA lateral-flow assay for diagnosing active Schistosoma infections by using larger sample volumes. Parasit Vectors. 2015;8:241.","journal-title":"Parasit Vectors"},{"key":"6311_CR43","doi-asserted-by":"publisher","first-page":"bpad006","DOI":"10.1093\/biomethods\/bpad006","volume":"8","author":"IV Fasogbon","year":"2023","unstructured":"Fasogbon IV, Aja PM, Ondari EN, Adebayo I, Ibitoye OA, Egesa M, et al. UCP-LF and other assay methods for schistosome circulating anodic antigen between 1978 and 2022. Biol Methods Protoc. 2023;8:bpad006.","journal-title":"Biol Methods Protoc."}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-024-06311-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-024-06311-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-024-06311-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T12:04:30Z","timestamp":1718625870000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-024-06311-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,17]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6311"],"URL":"https:\/\/doi.org\/10.1186\/s13071-024-06311-8","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,17]]},"assertion":[{"value":"17 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol of the SchistoBreak project, of which this study is part, received a waiver from the ethics committee of Switzerland (Ethikkommission Nordwest- und Zentralschweiz; EKNZ; project-ID: Req-2019-00951) before the onset of the project in 2019. Ethical approval of the study protocol was granted and is renewed annually by the Zanzibar Health Research Institute (ZAHRI). The latest extension was granted for one year in March 2023 (ZAHREC\/04\/AMEND\/MARCH\/2023\/03).Potential participants were informed about the purpose and procedures of the study by the local research team. Upon selection, individuals invited to participate in the study were provided with an information sheet detailing the study procedures and potential risks and benefits involved in participation, and with an informed consent form (ICF). For all participating children\u2009<\u200918\u00a0years of age, the ICF was to be signed by their parents or legal guardians. Additionally, children aged 12\u201317\u00a0years were requested to sign an assent form for their participation in the study. Adult participants were invited to sign their own ICF. Only individuals who submitted a signed ICF were eligible to participate.The local language Kiswahili was used for communication during information meetings, informed consent procedure, questionnaire survey, and the FGD. All documents used for local application were translated from English into Kiswahili with the support of the local research team and validated before use.The collection of urine samples from patients in health facilities was done by the individual in private in the toilet of the health facility. Caregivers provided support to children aged 4\u00a0years if needed. All patients positive for microhaematuria or infected with <i>Schistosoma\u00a0haematobium<\/i> were offered praziquantel (40\u00a0mg\/kg oral dose) free of charge for treatment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of her picture (with herself being shown) as a graphical abstract has been obtained from Naomi C. Ndum (first author of this paper).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"263"}}